Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
29.03
+12.04 (70.87%)
At close: Feb 10, 2026, 4:00 PM EST
28.36
-0.67 (-2.31%)
After-hours: Feb 10, 2026, 7:59 PM EST
Evommune Market Cap
Evommune has a market cap or net worth of $915.14 million as of February 10, 2026.
Market Cap
915.14M
Enterprise Value
839.85M
1-Year Change
n/a
Ranking
Category
Stock Price
29.03
Market Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has increased from $481.24M to $915.14M, an increase of 90.16%. That is a compound annual growth rate of 1,081.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 535.59M | -0.76% |
| Dec 31, 2025 | 539.69M | 12.15% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Janux Therapeutics | 813.50M |
| Omeros | 808.97M |
| Arbutus Biopharma | 808.72M |
| Maravai LifeSciences Holdings | 802.92M |
| MapLight Therapeutics | 794.27M |
| YD Bio | 792.86M |
| MiMedx Group | 779.02M |
| KalVista Pharmaceuticals | 764.26M |